Cathepsin K-Mediated Phenotypic Switching of Pulmonary Artery Smooth Muscle Contributed to the Development of Chronic Stress-related Pulmonary Hypertension in Mice

Abstract Aims Exposure to chronic psychological stress is a risk factor for metabolic pulmonary artery hypertension (PAH). Given the critical role of lysosomal cathepsin K (CTSK) in human pathobiology, we examined the role of CTSK in stress-related PAH, focusing on TGFβ/TGF-βR2-SMAD2/3 signaling-mediated switching of the phenotypical changes pf pulmonary artery smooth muscle cells (PASMCs). Methods and Results Eight-week-old male wild-type (CTSK +/+ ) and CTSK-knockout (CTSK −/− ) mice were subjected to hypoxia ± the tyrosine-kinase inhibitor SU-5416 with or without chronic restraint stress (CRS). Upon model establishment, the right-ventricular systolic pressure and vascular remodeling were quantified by echocardiography, micro-tip pressure sensor catheter, and biological and histomorphometry methods. Single-cell RNA sequencing (scRNA-seq) revealed elevated CTSK expression in PASMCs from idiopathic PAH patients. In mice, hypoxia ± SU-5416 induced CTSK expression and triggered PAH pathology that was markedly exacerbated by superimposed CRS. Genetic deletion of CTSK attenuated key features of PAH, including right-ventricular systolic pressure elevation and vascular remodeling, as well as a shift of PASMCs towards a synthetic phenotype characterized by increased expressions of extracellular-matrix genes (fibronectin, CTSK, and collagen I), a parallel induction of synthetic markers (TGF-β, VIM, and VCAN), and a decrease in contractile genes (SM22α, CNN1, and ATAC2). Mechanistically, CTSK formed a positive-feedback loop with TGF-β–SMAD2/3 signaling. In PASMCs, the silencing of CTSK abolished hypoxia- and stress-serum-induced cell proliferation and disrupted this loop, whereas CTSK overexpression amplified both. Conclusions These results identified CTSK as a critical contributor to PAH pathogenesis, particularly under chronic stress conditions. CTSK drives disease progression by enforcing a self-amplifying CTSK–TGF-β–SMAD2/3 circuit that switches PASMC phenotype change and proliferation.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-11565789/v1
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Cathepsin K-Mediated Phenotypic Switching of Pulmonary Artery Smooth Muscle Contributed to the Development of Chronic Stress-related Pulmonary Hypertension in Mice

Shangzhi Shu, Xueling Yue, Meiping Zhang, Xian Wu Cheng et al.
3 links
Research Square
Pulmonary Hypertension Research and Treatments
preprint

Cathepsin K-Mediated Phenotypic Switching of Pulmonary Artery Smooth Muscle Contributed to the Development of Chronic Stress-related Pulmonary Hypertension in Mice

Shangzhi Shu, Xueling Yue, Meiping Zhang, Xian Wu Cheng, Jinshun Piao, Songzhen Zhao, Miao Li, Chaoqun Huang, Meiling Piao, Chunzi Jin, Mantong Zhao, Ran Chen
preprint en

Abstract

Abstract Aims Exposure to chronic psychological stress is a risk factor for metabolic pulmonary artery hypertension (PAH). Given the critical role of lysosomal cathepsin K (CTSK) in human pathobiology, we examined the role of CTSK in stress-related PAH, focusing on TGFβ/TGF-βR2-SMAD2/3 signaling-mediated switching of the phenotypical changes pf pulmonary artery smooth muscle cells (PASMCs). Methods and Results Eight-week-old male wild-type (CTSK +/+ ) and CTSK-knockout (CTSK −/− ) mice were subjected to hypoxia ± the tyrosine-kinase inhibitor SU-5416 with or without chronic restraint stress (CRS). Upon model establishment, the right-ventricular systolic pressure and vascular remodeling were quantified by echocardiography, micro-tip pressure sensor catheter, and biological and histomorphometry methods. Single-cell RNA sequencing (scRNA-seq) revealed elevated CTSK expression in PASMCs from idiopathic PAH patients. In mice, hypoxia ± SU-5416 induced CTSK expression and triggered PAH pathology that was markedly exacerbated by superimposed CRS. Genetic deletion of CTSK attenuated key features of PAH, including right-ventricular systolic pressure elevation and vascular remodeling, as well as a shift of PASMCs towards a synthetic phenotype characterized by increased expressions of extracellular-matrix genes (fibronectin, CTSK, and collagen I), a parallel induction of synthetic markers (TGF-β, VIM, and VCAN), and a decrease in contractile genes (SM22α, CNN1, and ATAC2). Mechanistically, CTSK formed a positive-feedback loop with TGF-β–SMAD2/3 signaling. In PASMCs, the silencing of CTSK abolished hypoxia- and stress-serum-induced cell proliferation and disrupted this loop, whereas CTSK overexpression amplified both. Conclusions These results identified CTSK as a critical contributor to PAH pathogenesis, particularly under chronic stress conditions. CTSK drives disease progression by enforcing a self-amplifying CTSK–TGF-β–SMAD2/3 circuit that switches PASMC phenotype change and proliferation.

Research Square
First Hospital of Jilin University (CN), Yanbian University Hospital (CN)
National Natural Science Foundation of China, People's Government of Jilin Province
Good health and well-being
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon